Table 6 Studies used in the meta-analysis.
From: A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis
Dataset(s) | Sequencing platform | Sample size P: # of patients N: # of samples | Disease | Time point | Tissue type |
|---|---|---|---|---|---|
NCT02310750 (PF-06700841) | Affymetrix human genome U133 plus 2.0 array | P = 30, N = 60 | Psoriasis | Baseline | Skin lesional, non-lesional (paired) |
NCT03210961(PF-06826647) | Affymetrix human genome U133 plus 2.0 array | P = 40, N = 80 | Psoriasis | Baseline | Skin lesional, non-lesional (paired) |
NCT01710046 (CP-6890, 550) | Affymetrix human genome U133 plus 2.0 array | P = 12, N = 24 | Psoriasis | Baseline | Skin lesional, non-lesional (paired) |
NCT02840721 (PF-06480605) | RNA-seq | P = 39, N = 78 | Ulcerative colitis | Baseline | Colon lesional, non-lesional (paired) |
NCT01620255 (PF-00547659) | RNA-seq | P = 70, N = 140 | Ulcerative colitis | Baseline | Colon lesional, non-lesional (paired) |
Unpublished Pfizer internal collection | RNA-seq | P = 18, N = 36 | Ulcerative colitis | Baseline | Colon lesional, non-lesional (paired) |
